分子靶向药物副反应的诊断和处理.pptVIP

常见分子靶向药物的分类 常见分子靶向药物的分类（续） First, let us look at the adjuvant therapy in pancreatic cancer. At the present moment, surgical resection is still the only treatment that can offer cure to patients with Ca pancreas. However, only a small proportion of patients get cure as evidenced by around 5 yr survival rate as low as 10%. As most of you and investigators might be aware, adjuvant therapy is important to potentially improve the outcome of such a deadly disease. Comments. When we take of look of the survival figures between clinical trials, you can see for surgery alone, the 5 yrs survival rate